-
Gilead Sciences (GILD) Q1 2021 Earnings Call Transcript
30 Apr 2021 04:50 GMT
Image source: The Motley Fool.
Gilead Sciences (NASDAQ:GILD)
Q1 2021 Earnings … standing by. Welcome to the Gilead Sciences first-quarter 2021 earnings conference … today without the vision of John Martin, Gilead's chief executive …
-
Is Gilead Sciences a Buy?
11 Oct 2020 11:31 GMT
… . A real-life example is Gilead Sciences (NASDAQ:GILD), where management is … each has left their mark. John Martin, the company's CEO …
-
Gilead Sciences snares Roche veteran O'Day as CEO
10 Dec 2018 10:08 GMT
(Reuters) - Drugmaker Gilead Sciences Inc on Monday named Roche … Executive John Milligan and Chairman John Martin would step down at the …
-
Gilead Sciences hires Roche executive Daniel O'Day as CEO
10 Dec 2018 06:51 GMT
(Reuters) - Drugmaker Gilead Sciences Inc (NASDAQ:GILD) named Roche … Executive John Milligan and Chairman John Martin would step down at the …
-
Gilead Sciences Appoints Roche Executive Daniel O'Day As Chairman And CEO
10 Dec 2018 06:22 GMT
Gilead Sciences Inc. (GILD) said Monday that … the future," said John Martin, PhD, Chairman, Gilead Sciences Board of Directors.
O …
-
Gilead Sciences to hire Roche executive O'Day as new CEO
10 Dec 2018 04:33 GMT
Drugmaker Gilead Sciences Inc will name Roche Holding … Executive John Milligan and Chairman John Martin would step down at the …
-
Is Gilead Sciences' Sudden Change in Leadership a Good Thing?
30 Jul 2018 15:49 GMT
Gilead Sciences (NASDAQ:GILD) announced last week … CEO John Milligan and Chairman John Martin will step down from their … owns shares of and recommends Gilead Sciences. The Motley Fool has a …
-
Gilead Sciences CEO Milligan to Depart for “New Opportunities”
27 Jul 2018 03:25 GMT
… as president and CEO of Gilead Sciences (NASDAQ: GILD) at the end … also announced that board chairman John Martin will step down. Martin will …
-
Gilead Sciences CEO John Milligan To Step Down - Quick Facts
25 Jul 2018 22:01 GMT
Gilead Sciences, Inc. (GILD) announced that John … end of the year.
Additionally, John Martin, Chairman of the Board, has … CEO, Executive Chairman and Chairman.
Gilead Sciences, Inc. also announced that the …
-
Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing
23 May 2018 10:30 GMT
… Dr. Bischofberger was at Gilead Sciences for almost 30 years, … Omega Funds, BellCo Capital, John Martin, Ph.D., Norbert Bischofberger, … be pursued,” said Dr. John Martin. “Norbert is ideally positioned … the early formation of Gilead Sciences. He joined the …
About
© 1995-2025